StockData

Bon Natural Life Ltd (BON) company profile

BONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends September 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Sep 30, 2025Last filing: 20-F on Jan 23, 2026Score 0/30
$1.07−0.02 (-1.83%)

Close on Nov 17, 2026Market cap $8.70MP/E –Yield –

About Bon Natural Life

Medicinal Chemicals & Botanical Products, SIC 2833

Bon Natural Life Limited is a holding company that operates primarily through its operating subsidiaries in the People's Republic of China. The company engages in the research, development, manufacture, and commercialization of specialized plant-extracted natural ingredients. Its core product portfolio comprises three principal categories: fragrance compounds, health supplements, and bioactive food ingredients. These offerings are distributed to manufacturer and wholesale customers across various downstream consumer markets.

The company maintains operational presence and subsidiaries across multiple locations, including Xi'an, Tongchuan, Dali County, Guangzhou, and Hangzhou in China, alongside corporate entities organized in the Cayman Islands, Hong Kong, and Nevada in the United States. Its principal executive offices are headquartered in Xi'an, Shaanxi Province, China.

Summary of the business section of Bon Natural Life's latest annual report, written by StockData.

Company profile

Company

Legal name
Bon Natural Life Ltd
Headquarters
Shaanxi, F4
Address
Room 601, Block C, Gazelle Valley, No.69, Jinye Road, High-Tech Zone, Xian 710076
Phone
0086-29-88346301
Website
bnlus.com
Employees
96, Sep 30, 2025
Industry
Medicinal Chemicals & Botanical Products
Incorporated in
E9
Fiscal year ends
September 30
Auditor
YCM CPA INC, Irvine, California

Stock & identifiers

Ticker
BON
Exchange
Nasdaq
IPO date
Jun 25, 2021
Shares outstanding
8M, Sep 30, 2025
Filer category
Non-accelerated filer<br>Emerging growth company
Stock splits
1-for-25 reverse, May 19, 2025; 1-for-10 reverse, Apr 11, 2024
SEC CIK
1816815
FIGI
BBG00YG4WZS6
Share class FIGI
BBG00YG4X0M8
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
jing liuChief Technology Officer, Director1,496
Yongwei HuChief Executive Officer, Director80,177
Yingchun XueChief Operating Officer120
Xin MaChief Financial Officer–
Chen WenjuanChief Marketing Officer80
Gao ZhixiangDirector–
Jing Veronica ChenDirector–
Jianjun GaoDirector–

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Jun 25, 2021
Securities offered
330,000
Exchange
Nasdaq
First trading day
Jun 24, 2021
First-day close
$7.20
Lock-up ends (est.)
Dec 21, 2021

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“of September 30, 2025, we had a total of 96 full time employees, of which 50 are in production, 5 are in quality control, 15 are in R&D,”

Corporate history

Events identified from SEC filings

See a number that looks wrong?